Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 398 of 1,261
  1. US 10774076

    Benzazole compounds and methods for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  2. US 10772942

    Lyophilized factor IX formulations

    BIOVERATIV THERAPEUTICS INC. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  3. US 10772333

    Mollusk-killing biopesticide

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  4. US 10772504

    Apparatus, systems and methods for intraoperative imaging

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  5. US 10772846

    Methods and compositions for treating and preventing arthritis

    Montefiore Medical Center · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  6. US 10772849

    Methods of regulating cannabinoid receptor activity-related disorders and diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  7. US 10772862

    Lipid scavenging in Ras cancers

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  8. US 10772865

    Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

    Coherus BioSciences, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  9. US 10772880

    Method of treatment with tradipitant

    VANDA PHARMACEUTICALS INC. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  10. US 10772861

    Administration of serine protease inhibitors to the stomach

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  11. US 10772995

    Cross-linked fatty acid-based biomaterials

    ATRIUM MEDICAL CORPORATION · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  12. US 10772911

    Cell free compositions for cellular restoration and methods of making and using same

    Advanced ReGen Medical Technologies, LLC · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  13. US 10772906

    Modulation of Factor 11 expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  14. US 10772924

    Therapeutic use of chardonnay seed products

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  15. US 10772956

    Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  16. US 10772959

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  17. US 10772960

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  18. US 10772963

    Etanercept formulations stabilized with xylitol

    Coherus BioSciences, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  19. US 10772971

    Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  20. US 10774066

    Prodrugs of NRF2 activating compounds and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  21. US 10774083

    Heterocyclic amide compound

    Takeda Pharmaceutical Company Limited · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  22. US 10774181

    N-maleimidyl polymer derivatives

    Nektar Therapeutics · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  23. US 10774118

    Peptides having reduced toxicity that stimulate cholesterol efflux

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  24. US 10774121

    Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.